HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice.

Abstract
Traumatic brain injury (TBI) results in cognitive impairment, which can be long-lasting after moderate to severe TBI. Currently, there are no FDA-approved therapeutics to treat the devastating consequences of TBI and improve recovery. This study utilizes a prodrug of 2,4-dinitrophenol, MP201, a mitochondrial uncoupler with extended elimination time, that was administered after TBI to target mitochondrial dysfunction, a hallmark of TBI. Using a model of cortical impact in male C57/BL6 mice, MP201 (80 mg/kg) was provided via oral gavage 2-hr post-injury and daily afterwards. At 25-hr post-injury, mice were euthanized and the acute rescue of mitochondrial bioenergetics was assessed demonstrating a significant improvement in both the ipsilateral cortex and ipsilateral hippocampus after treatment with MP201. Additionally, oxidative markers, 4-hydroxyneneal and protein carbonyls, were reduced compared to vehicle animals after MP201 administration. At 2-weeks post-injury, mice treated with MP201 post-injury (80 mg/kg; q.d.) displayed significantly increased cortical sparing (p = .0059; 38% lesion spared) and improved cognitive outcome (p = .0133) compared to vehicle-treated mice. Additionally, vehicle-treated mice had significantly lower (p = .0019) CA3 neuron count compared to sham while MP201-treated mice were not significantly different from sham levels. These results suggest that acute mitochondrial dysfunction can be targeted to impart neuroprotection from reactive oxygen species, but chronic administration may have an added benefit in recovery. This study highlights the potential for safe, effective therapy by MP201 to alleviate negative outcomes of TBI.
AuthorsW Brad Hubbard, Christopher L Harwood, John G Geisler, Hemendra J Vekaria, Patrick G Sullivan
JournalJournal of neuroscience research (J Neurosci Res) Vol. 96 Issue 10 Pg. 1677-1688 (10 2018) ISSN: 1097-4547 [Electronic] United States
PMID30063076 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2018 Wiley Periodicals, Inc.
Chemical References
  • Neuroprotective Agents
  • Prodrugs
  • Uncoupling Agents
  • 2,4-Dinitrophenol
Topics
  • 2,4-Dinitrophenol (pharmacology)
  • Animals
  • Brain Injuries, Traumatic (chemically induced, drug therapy, metabolism, pathology)
  • Disease Models, Animal
  • Energy Metabolism (drug effects)
  • Male
  • Memory (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria (drug effects, metabolism)
  • Neurons (drug effects, metabolism, pathology)
  • Neuroprotective Agents (pharmacology)
  • Oxidative Stress (drug effects)
  • Oxygen Consumption (drug effects)
  • Prodrugs (pharmacology)
  • Recognition, Psychology (drug effects)
  • Uncoupling Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: